Category: Press Releases
The Longevity Science Foundation Launches
September 30, 2021
The Longevity Science Foundation has launched today. This new Swiss foundation has confirmed that it will be committing over $1 billion in the next ten years to research, institutions, and
Underdog Pharmaceuticals Concludes $10M Financing Round
September 23, 2021
The investment company Kizoo has announced that one of the companies in its portfolio, Underdog Pharmaceuticals, has received $10 million in funding from a Series Seed II round. Mike Kope,
Underdog Pharmaceuticals Receives Accelerated Designation
September 10, 2021
Underdog Pharmaceuticals (Now called Cyclarity Therapeautics) has just issued a press release announcing that UDP-003, a compound being studied for its effectiveness against oxidized cholesterol, has been given an Innovation
The Longevity Investors Conference
August 24, 2021
Press Release The second investors only conference focusing on Longevity will take place on the 27th of September 2021 Zug, 24. August 2021 – The Longevity Investors Conference targets the
The Longevity Science Foundation Launches
September 30, 2021
The Longevity Science Foundation has launched today. This new Swiss foundation has confirmed that it will be committing over $1 billion in the next ten years to research, institutions, and projects advancing healthy human longevity and extending the healthy human lifespan to more than 120 years.
Underdog Pharmaceuticals Concludes $10M Financing Round
September 23, 2021
The investment company Kizoo has announced that one of the companies in its portfolio, Underdog Pharmaceuticals, has received $10 million in funding from a Series Seed II round. Mike Kope, who is well-known for his work in SENS Research Foundation, is the co-CEO of Underdog. As
Underdog Pharmaceuticals Receives Accelerated Designation
September 10, 2021
Underdog Pharmaceuticals (Now called Cyclarity Therapeautics) has just issued a press release announcing that UDP-003, a compound being studied for its effectiveness against oxidized cholesterol, has been given an Innovation Passport under the UK’s Innovative Licensing and Access Pathway program. This is similar to the Fast
The Longevity Investors Conference
August 24, 2021
Press Release The second investors only conference focusing on Longevity will take place on the 27th of September 2021 Zug, 24. August 2021 – The Longevity Investors Conference targets the global investor community and brings private and institutional investors from (U)HNWIs, Family Offices, VCs, Private Equity